Search details
1.
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
Curr Treat Options Oncol
; 22(8): 69, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-34110510
2.
H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing.
Nucleic Acids Res
; 43(5): 2560-74, 2015 Mar 11.
Article
in English
| MEDLINE | ID: mdl-25712104
3.
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Curr Oncol
; 30(1): 1032-1045, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36661728
4.
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers.
Onco Targets Ther
; 16: 585-613, 2023.
Article
in English
| MEDLINE | ID: mdl-37485307
5.
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Dig Liver Dis
; 55(5): 655-660, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36513569
6.
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.
J Natl Cancer Inst
; 115(7): 796-804, 2023 07 06.
Article
in English
| MEDLINE | ID: mdl-37042716
7.
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives.
Cancers (Basel)
; 14(19)2022 Sep 29.
Article
in English
| MEDLINE | ID: mdl-36230686
8.
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients.
Front Oncol
; 12: 852583, 2022.
Article
in English
| MEDLINE | ID: mdl-35530345
9.
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis.
Explor Target Antitumor Ther
; 2(3): 227-239, 2021.
Article
in English
| MEDLINE | ID: mdl-36046436
10.
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.
Front Oncol
; 11: 736104, 2021.
Article
in English
| MEDLINE | ID: mdl-34660299
11.
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy.
J Clin Med
; 10(7)2021 Apr 04.
Article
in English
| MEDLINE | ID: mdl-33916569
12.
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
Ann Transl Med
; 9(3): 251, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33708878
13.
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab.
J Clin Med
; 10(5)2021 Mar 02.
Article
in English
| MEDLINE | ID: mdl-33801320
14.
Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing.
Cancers (Basel)
; 12(10)2020 Sep 23.
Article
in English
| MEDLINE | ID: mdl-32977434
Results
1 -
14
de 14
1
Next >
>>